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Summary Background: Tick-borne rickettsioses are of emerging importance in today’s
travel medicine but have until recently received little attention. We describe the cur-
rent knowledge of tick-borne rickettsioses as they relate to international travel, their
microbiological diagnosis, treatment, possible prevention, and future prospects.
Methods: Literature-based review and personal observations.
Results: During the last decade, some 400 cases of tick-borne rickettsioses have
been reported in international travellers, the vast majority being African tick bite
fever caused by Rickettsia africae and Mediterranean spotted fever caused by Rick-
ettsia conorii. Only a minority of infected travellers can recall a preceding tick bite.
Most patients present with a mild-to-moderately severe ﬂu-like illness typically ac-
companied by a cutaneous rash and an inoculation eschar at the site of the tick bite,
but potentially life-threatening disease with disseminated vaculitis is occasionally
seen. Deﬁnite microbiological conﬁrmation of tick-borne rickettsioses by isolation or
antigen detection is only available at reference laboratories and diagnosis must in
most cases rely on clinical and epidemiological data supported by serology. Doxycy-
cline is the recommended treatment for tick-borne rickettsioses and prevention is
based on personal protective measures against tick bites when travelling in endemic
areas.
Conclusion: Tick-borne rickettsiosis should be suspected in febrile returnees from
endemic areas, especially in cases with skin eruptions. Travellers to endemic areas
should be encouraged to use personal protective measures against tick bites.
© 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
Tick-borne rickettsioses are acute ﬂu-like diseases
frequently presenting with fever, severe headache,
myalgia, skin rash, and inoculation eschars at the
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site of the tick bite. The diseases are caused by
spotted fever group rickettsiae; obligate intracel-
lular Gram-negative coccobacilli, which are main-
tained in nature through complex cycles involving
mammal and tick reservoirs and tick vectors, with
humans only as incidental hosts. Most tick-borne
rickettsioses are conﬁned to certain geographi-
cal areas limited by the presence of their tick
vectors, and few are present on more than one
continent.1
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Table 1 Current classiﬁcation of tick-borne rickettsioses.
Human disease Organism Principal vectors Geographic distribution Reported in
international
travellers
African tick bite fever Rickettsia africae Amblyomma ticks Sub-Saharan Africa, French West Indies Yes
Mediterranean spotted fever Rickettsia conorii Rhipicephalus &
Haemaphysalis ticks
Mediterranean littoral to Indian subcontinent,
sub-Saharan Africa
Yes
Indian tick typhus Indian tick typhus rickettsia Rhipicephalus ticks India Yes
Astrakhan fever Astrakhan fever rickettsia Rhipicephalus ticks Caspian littoral, SE Europe, Central Africa Yes
Israeli spotted fever Israeli tick typhus rickettsia Rhipicephalus ticks Eastern Mediterranean littoral, SW Europe No
Rocky Mountain spotted fever Rickettsia rickettsii Dermacentor &
Amblyomma ticks
North and South America Yes
Queensland tick typhus Rickettsia australis Ixodes ticks Eastern Australia Yes
Unnamed Rickettsia aeschlimannii Hyalomma &
Rhipicephalus ticks
Mediterranean area, Morocco, sub-Saharan Africa Yes
North Asian tick typhus Rickettsia sibirica Dermacentor &
Haemaphysalis ticks
Former Soviet Asia, China, European Russia Yes
Flinder’s island spotted fever Rickettsia honei Ticks of several genera Australia, SE Asia, NW America No
Japanese spotted fever Rickettsia japonica Ticks of several genera SW Japan No
Unnamed ‘Rickettsia heilongjiangii’ Dermacentor ticks NE China No
Unnamed Rickettsia slovaca Dermacentor ticks Southern and eastern Europe No
Unnamed Rickettsia helvetica Ixodes ticks Central and northern Europe No
Unnamed ‘Rickettsia mongolotimonae’ Hyalomma ticks Mongolia, France, sub-Saharan Africa No
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Tick-borne rickettsioses have traditionally been
considered rare among international travellers and
until 1995 only some 80 cases had been reported in
the literature.2—9 In most published studies on im-
ported fevers, the incidence rate of rickettsioses is
very low and ranges from 0—2%.10—12 However, due
to low index of suspicion and poor availability of
microbiological diagnostic tests, travel-associated
tick-borne rickettsioses could be largely unrecog-
nised and under-reported. Three recent studies
support this assumption. In Switzerland, it is es-
timated that rickettsial infection is actually the
third most frequent cause of imported acute febrile
diseases, only surpassed by malaria and enteric
fever.13 In Swedish travellers to southern Africa,
the estimated risk of contracting rickettsioses in-
creased during 1997—2001 and is now four to ﬁve
times higher than the risk of acquiring malaria in
the same region.14 Finally, in 530 German trav-
ellers who presented at an out-patient travel clinic
with fever after a trip to southern Africa, as many
as 11% had serological evidence of recent spotted
fever group rickettsioses.15
Recently, the number of reported cases of
travel-associated tick-borne rickettsioses has risen
signiﬁcantly world-wide. This could be explained by
increased travel to endemic areas, including eco-
tourism, increased disease activity, or increased di-
agnostic awareness. Of the 15 currently-recognised
tick-borne rickettsioses, eight have been reported
in international travellers: African tick bite fever,
Mediterranean spotted fever, Indian tick typhus,
Astrakhan fever, Rocky Mountain spotted fever,
Queensland tick typhus, Rickettsia aeschlimannii
infection and North Asian tick typhus (Table 1). This
review provides an outline of the current knowl-
edge of tick-borne rickettsioses as they relate to
international travel, their microbiological diag-
nosis, treatment, possible prevention, and future
prospects.
African tick bite fever
African tick bite fever is caused by Rickettsia
africae and is endemic in large parts of sub-Saharan
Africa and the French West Indies.16,17 The disease
is transmitted by ungulate ticks of the Amblyomma
genus, principally Amblyomma hebraeum and Am-
blyomma variegatum, and is typically acquired in
rural areas where wild game or domestic cattle are
present. The implicated tick vectors, which are
active throughout the year in many areas, exhibit
a notoriously aggressive behaviour and actively at-
tack humans. An exposed individual may thus be
bitten by many ticks simultaneously, and in a given
group, several members may be attacked on the
same occasion. For instance, during the investiga-
tion of an outbreak of African tick bite fever among
Italian safari tourists to South Africa, as many as
53 tick bites, of which 34 subsequently developed
into inoculation eschars, were documented in ﬁve
patients.18 Other important features of African tick
bite fever include prominent neck muscle myalgia,
headache, regional lymphadenitis, and, less fre-
quently, a vesicular cutaneous rash and aphthous
stomatitis.19,20 The clinical course is frequently
mild, but may be complicated by reactive arthri-
tis and prolonged fever. To date, no fatal cases
of documented African tick bite fever have been
reported.
African tick bite fever was virtually unknown
outside endemic areas until some ten years ago.
Since then, more than 350 travel-associated cases
have been reported from Europe, North Amer-
ica, Australia, Argentina, and Japan.3,7,17—36 Most
cases are infected in South Africa, where many
popular wildlife attractions are highly endemic
for R. africae infection37 and where the aboli-
tion of apartheid in the early 1990s was followed
by an unprecedented rise in international safari
tourism. African tick bite fever has been reported
in a wide spectrum of travellers, including leisure
safari tourists, foreign aid workers, ﬁlm crew mem-
bers, game hunters, students, sports competitors,
and deployed soldiers.17 In a recent prospective
cohort study of 940 short-term travellers to ru-
ral sub-equatorial Africa, the estimated incidence
rates of African tick bite fever ranged from 4.0—
5.3%.19 These estimates are notable and widely
exceed those reported for other travel-associated
tropical fevers in temporary visitors to sub-Saharan
Africa. In the same study, game hunting, travel
to southern Africa (i.e. where A. hebraeum is the
principal vector of R. africae), and travel during
the rainy summer season (i.e. when tick popula-
tions peak in most endemic areas) were identiﬁed
as independent risk factors.
Mediterranean spotted fever
Mediterranean spotted fever caused by Rickettsia
conorii is endemic around the Mediterranean basin,
the Middle East, India, and in parts of sub-Saharan
Africa. The principal vectors are dog ticks of the
Rhipicephalus and Haemaphysalis genera which
only rarely bite humans. Nevertheless, the an-
nual incidence rate may locally be very high,
e.g. 50 cases/100,000 inhabitants in southern
France, where most cases are reported from May
to September.38 Because of its close association
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with domestic dogs, Mediterranean spotted fever
is usually conﬁned to urban and suburban areas.
Important clinical features include a single inoc-
ulation eschar (in 70% of the cases) and a gener-
alised maculopapular rash (in >95% of the cases).39
Complications are relatively common, and if left
untreated the mortality rate may exceed 2%.
Mediterranean spotted fever is sometimes diag-
nosed in international travellers. Recent travel-
associated cases, in most instances infected in
the Mediterranean area, have been reported
from the United Kingdom, Germany, Switzerland,
Scandinavia, and North America.13,40—45 A Nor-
wegian male contracted Mediterranean spotted
fever twice during visits to a village in Sicily,
Italy, in 1997 and 1999, and on both occasions
he had played with local dogs.41 Travelling dogs
may carry R. conorii-infected Rhipicephalus san-
guineus ticks to non-endemic areas, as demon-
strated in northern France and Switzerland,46,47
and in The Netherlands, three cases of human
Mediterranean spotted fever were linked to dogs
that had recently returned from the Mediterranean
basin.48
Indian tick typhus
Indian tick typhus is caused by Indian tick typhus
rickettsia, a species closely related to R. conorii,
and is transmitted by the brown dog tick R. san-
guineus. The disease is endemic in India, where it
was described as early as the beginning of the 20th
century. Although the clinical presentation resem-
bles that of Mediterranean spotted fever, the rash
in Indian tick typhus is frequently purpuric, and an
inoculation eschar is rarely found.49
A case of Indian tick typhus was reported in a
French 25-year-old female who fell ill at the end
of a one-month stay in India. The clinical presenta-
tion was moderately severe with a generalised mac-
ulopapular rash with petechiae but no inoculation
eschar.50
Astrakhan fever
Astrakhan fever is caused by Astrakhan fever rick-
ettsia, another spotted fever group rickettsia
closely related to R. conorii. Since 1983, some 1000
cases have been reported in the Caspian basin,
where the dog tick Rhipicephalus pumilio is the
principal vector.51 Recently, Astrakhan fever rick-
ettsia was detected in R. sanguineus ticks collected
from dogs and military personnel in Kosovo.52 The
clinical picture mimics that of Mediterranean spot-
ted fever, although an inoculation eschar may be
seen in only some 20% of the cases.
Astrakhan fever was diagnosed in a French
36-year-old male who fell ill a few days after
a bush walk in Chad in October 2000. This case
was the ﬁrst outside Europe and suggests that
Astrakhan fever should be considered when evalu-
ating tick-borne rickettsioses in travellers to rural
sub-Saharan Africa.53
Rocky Mountain spotted fever
Rocky Mountain spotted fever is caused by Rick-
ettsia rickettsii and is transmitted by ticks of the
Dermacentor and Amblyomma genera. The princi-
pal endemic areas in North America comprise rural
areas of the Atlantic seaboard and in mid-western
USA where most cases occur from April to August.54
Some 500 cases are reported each year in the USA,
predominantly in children below 16 years of age. In-
oculation eschars are rarely seen in Rocky Mountain
spotted fever, and a generalised exanthema, typi-
cally purpuric, may be absent in some 10% of the
cases. The purpuric nature of the rash and the fact
that some patients with Rocky Mountain spotted
fevermay developmeningitis maymake this disease
difﬁcult to distinguish from meningiococcemia. Fa-
talities are not uncommon, but are usually associ-
ated with delay or failure in giving anti-rickettsial
therapy, absence of rash, or absence of tick expo-
sure history.55
Despite its signiﬁcant impact on local popula-
tions, Rocky Mountain spotted fever appears to be
rare in international travellers. In September 1988,
a German 24-year-old male fell ill 12 days after
being bitten by a tick during a camping holiday in
North Carolina.56 An American patient contracted
Rocky Mountain spotted fever in the USA but devel-
oped symptoms and was diagnosed while travelling
in France; this patient had an inoculation eschar
on the leg (D. Raoult, unpublished data). In 1992,
a Finnish 48-year-old female fell ill with probable
Rocky Mountain spotted fever shortly after return-
ing from a camping trip in mid-western USA (S.
Vene, personal communication).
Queensland tick typhus
Queensland tick typhus is caused by Rickettsia
australis and is transmitted by ticks of the Ixodes
genus in rural areas of eastern Australia, where
some 60 cases have been reported since 1946.57
About two thirds of the patients exhibit an inocula-
tion eschar and, as for African tick bite fever, the
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cutaneous rash is frequently vesicular rather than
maculopapular. Fatalities are rarely reported.58
A 16-year-old New Zealand girl fell ill with
Queensland tick typhus a few days after visiting a
crocodile farm in Queensland. The clinical course
was severe with renal failure, thrombocytopenia
and anemia, and necessitated intensive care.59
Rickettsia aeschlimannii infection
Rickettsia aeschlimannii, which was ﬁrst isolated in
1997, has been detected in Hyalomma marginatum
ticks collected from cattle in Morocco, Zimbabwe,
Niger, and Mali, and in a Rhipicephalus appendicula-
tus tick in South Africa. So far, only two human cases
have been reported world-wide: a local hunter in
South Africa with mild disease60 and a 36-year-old
male French traveller to Morocco in August 2000.61
The latter case presented with high fever, a gener-
alised maculopapular cutaneous rash, and a single
inoculation eschar, but recovered uneventfully on
doxycycline.
North Asian tick typhus
North Asian tick typhus (or Siberian tick typhus),
caused by Rickettsia sibirica, is endemic in large
parts of rural northern Asia, including the former
USSR, China and Mongolia. Infections may be very
common locally with seropositivity rates reported
to exceed 60% in some endemic areas. Most cases
occur between May and September.62
North Asian tick typhus appears to be very rare
among international travellers, but was recently
reported in a 55-year-old female volunteer in Mon-
golia who presented with ﬂu-like symptoms and an
eschar on the back of her head upon returning to
the UK.63 In a prospective study of 13 North Amer-
ican palaeontologists deployed to the Gobi desert
during two consecutive summer seasons, four sub-
jects were diagnosed with the disease. The clin-
ical presentation included fever, headache, rash,
inoculation eschars with regional lymphadenitis,
and diarrhoea. Three of the four cases were given
anti-rickettsial chemotherapy and all recovered
uneventfully.64
Microbiological diagnosis
The microbiological diagnosis of rickettsioses is not
straight-forward. Culture, the ultimate method, is
technically cumbersome and restricted to refer-
ence centres to which samples must be shipped.65
Also, culture requires biohazard facilities, should
optimally be inoculated on the day of sampling, and
is notoriously negative in cases with prior antibi-
otic treatment.66 PCR detection can be performed
in any laboratory equipped for molecular diagno-
sis, and may be applied to an array of samples,
including blood, serum and tissue biopsies. The in-
oculation eschar, however, is the most useful biopsy
sample to assay. Various genes can be used, includ-
ing those encoding the citrate synthase (gltA),67
the outer membranes rOmpA (ompA)68 and rOmpB
(ompB)69 and PS120 (gene D).70 Recently, a PCR as-
say with increased sensitivity, named suicide PCR,
has been developed to detect DNA from blood and
tissue samples.20,52,71—73 This technique is a nested
PCR using single-use primers targeting a gene never
ampliﬁed previously in the laboratory.
Serology is the most commonly used microbio-
logical method for diagnosing rickettsial infections
world-wide. However, tests available in commer-
cial laboratories, such as the archaic Weil-Felix
test and immunoﬂuorescence assay, are often un-
able to distinguish reliably between infections with
different rickettsial species.65 With immunoﬂoures-
cence assay, the considered the serologic refer-
ence method, diagnostic antibodies are usually
not detected until the second week of illness for
most rickettsioses. In African tick bite fever, sero-
conversion may occur even later, or not at all in
cases treated early with doxycycline.74 More spe-
ciﬁc serologic methods, including Western blotting
and cross-adsorption technique, are currently only
available at reference centres.
Treatment
More than 50 years after their introduction, tetra-
cyclines still remain the drugs of ﬁrst choice in
the treatment of tick-borne rickettsioses.75 Doxy-
cycline 100mg bid should be given for ﬁve days,
or until 48 hours after defervescence. In pregnant
women, chloramphenicol, josamycin, or a com-
bination of rifampin and erythromycin may be
administered.76 Early antibiotic therapy should be
prescribed in any suspected tick-borne rickettsio-
sis. Patients with a severe course should be hospi-
talised and treated with doxycycline intravenously
up to 24 hours after defervescence. Corticosteroids
have not proven useful.
Prevention
It should be stressed that the overall risk for con-
tracting tick-borne rickettsioses is low, or very low,
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for most international travellers. Many of the dis-
eases occur only in remote areas infrequently af-
fected by modern tourism, and most of the im-
plicated tick vectors are highly adapted to their
animal hosts and only bite humans under excep-
tional circumstances.77 Nevertheless, certain trav-
ellers are at risk and should be informed about pre-
ventive measures against tick bites:
1. Travellers to the Mediterranean littoral and
other areas highly endemic for Mediterranean
spotted fever should avoid physical contact
with local dogs, including pet dogs, which have
been implicated in disease among temporary
visitors.40 Travellers who bring their own dogs
should consider treating them with acaricides.
2. When hiking during the tick season in rural
areas with known rickettsial activity, e.g. in
eastern USA (Rocky Mountain spotted fever), in
sub-Saharan Africa (African tick bite fever and
other tick-borne rickettsioses), or northern Asia
(North Asia tick typhus) travellers should be rec-
ommended to wear protective clothing ideally
impregnated with acaricides, regularly check
for and swiftly remove any ticks from cloth-
ing or skin, and use topical insect repellents
on exposed skin.77,78 Unfortunately, most com-
mercially available skin repellents, e.g. those
based on diethyl-3-methylbenzamide (DEET),
piperidine compounds or citronella oil, have
only short-lasting efﬁcacy against ticks, typi-
cally for <2 hours.79—81 Certainly, products con-
taining >33% DEET may have more long-lasting
activity,82 but lotions containing >19.5% are not
widely available outside the USA. Travellers to
rural sub-Saharan Africa should be informed that
the tick vectors of African tick bite fever are
locally very abundant on vegetation, are very
aggressive, are active the whole year in many
areas, and, as opposed to mosquitoes and most
other disease-transmitting insects, are active
24 hours a day.
3. If travellers returning from tick-infested areas
subsequently develop ﬂu-like symptoms, they
should be sure to mention the possible exposure
to their doctor.
Future prospects and conclusions
Given the signiﬁcant increase in international
travel (about 4% per annum),83 and notably to re-
mote areas in tropical and sub-tropical regions of
the world, it is likely that the number of cases
of travel-associated tick-borne rickettsioses will
continue to rise in the years to come. Moreover,
a more widespread use of culture and PCR will
provide more accurate diagnoses, and, indirectly,
reveal new epidemiological insights. For instance,
in rural sub-Saharan Africa, where until recently
African tick bite fever and Mediterranean spot-
ted fever were the only two recognised tick-borne
rickettsioses, we now know that also Astrakhan
fever, R. aeschlimannii infection, and probably
‘Rickettsia mongolotimonae’ infection,84 may be
encountered by international travellers. South-East
Asia is another region with soaring tourism and
where recent PCR-based studies have disclosed the
presence of several rickettsial species.85,86 Impor-
tantly, physicians evaluating febrile travellers who
have visited tick-infested areas during the pre-
ceding ten days should, even in the absence of a
inoculation eschar and skin rash, remember the
possibility of tick-borne rickettsiosis and consider
the institution of empiric anti-rickettsial therapy.
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